The Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) launched BIO-NIVESH ...

Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup ...

HRV Pharma announced it will invest Rs 150 crore to expand capabilities across two high-value and supply-constrained pharma segments, synthetic peptides and high-potency oncology APIs. The investment ...

The formulation integrates Ginsenoside phyto-exosomes, biomimetic peptides, copper peptides and stem cell-supportive actives to support follicular vitality, scalp health and the natural hair growth cy ...

She has held senior leadership roles at Eli Lilly, Elanco and Astellas Pharma, where she has focused on building and scaling ...

The growing use of non-surgical procedures in aesthetic dermatology is expanding the range of treatment options available for ...

Global pharma major Lupin announced that it has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets […] ...

Piyush Goyal, Union Minister of Commerce and Industry, Government of India, today inaugurated the Bharat Health Global Expo ...

Invagen Pharmaceuticals, a wholly owned subsidiary of Cipla announced that it has entered into a strategic partnership with Qilu Pharmaceutical, for the exclusive licensing and supply of QL2107, a ...

India’s ability to supply affordable medicines at scale is strategic infrastructure for patients, health systems and global ...

For years, China+1 has been the big story in India’s CDMO opportunity. Now, it is no longer enough. The shift away from China ...

Pivot Path emerged from Strides Pharma’s internal GCC. Are other pharma companies also following the same playbook? And if so ...